Varicella-Zoster Virus: Latency, Reactivation, and Why Chickenpox Becomes Shingles

A six-year-old gets chickenpox, recovers completely in two weeks, and is left with lifelong immunity. Sixty years later, the same person develops a burning pain on one side of their chest, followed three days later by a band of blisters in a dermatomal distribution. It's shingles, caused by the exact same virus that infected them in childhood, which has been hiding undetected in their dorsal root ganglia for six decades.

This is one of the most elegant demonstrations of viral latency in human medicine. VZV doesn't do what most viruses do after acute infection; get cleared entirely or cause chronic active disease. Instead, it retreats into sensory neurons, where it exists as a transcriptionally silent provirus, held in check by the host's VZV-specific T-cell immunity for years, sometimes decades. When that T-cell surveillance wanes; as it does naturally with age, or more acutely with immunosuppression — the virus reactivates, travels back down the axon to the skin, and causes disease again in the dermatome served by the ganglion where it has been hiding.

Understanding this latency-and-reactivation cycle is what makes VZV clinically coherent: it explains why shingles occurs specifically in older and immunocompromised patients, why the rash is unilateral and dermatomal (one ganglion reactivating at a time), why postherpetic neuralgia can persist for months after the rash resolves, and why a vaccine exists specifically for older adults to boost their waning VZV T-cell immunity before the virus gets a chance to reactivate.

Figure: Varicella-Zoster Virus (VZV)

Varicella is less contagious than measles, but more contagious than mumps and rubella.

Characteristic Features of VZV

• Double-stranded (ds) DNA virus.
• Member of the herpesvirus (human α-herpesvirus family).
• Single serotype (one attack of chickenpox gives lifelong immunity).
• Humans are the only known reservoir hosts.

Chickenpox

Transmission

Mode of transmission of chickenpox is direct contact with skin lesions, inhalation of aerosols from vesicular fluid of skin lesions of acute varicella or zoster, or aerosols of infected respiratory secretions. Person is contagious 1-2 days before the appearance of the rash until all blisters are crusted.

Pathogenesis

Varicella-zoster virus enters through the upper respiratory mucosa or the conjunctiva. VZV infects macrophages and pneumocytes in the respiratory mucosa. Virus spreads to the reticuloendothelial system, replicates in the regional lymph nodes, and enters the bloodstream (primary viremia). From the hematogenous route, it reaches the liver, and spleen and multiplies there. Secondary viremia occurs, and VZV present in infected mononuclear cells is transported to skin, respiratory tract, and neurons.

1. Skin: Virus replication in the epithelial cells leads to the development of typical rashes. Swelling of epithelial cells, ballooning degeneration, and accumulation of tissue fluids result in the formation of vesicles.
2. Respiratory tract: VZV is shed in the respiratory secretions of the infected individuals leading to the transmission of infection to other individuals.
3. Neurons: VZV travels from skin lesions along sensory nerve endings and establishes lifelong latency in the sensory ganglia. This includes the dorsal root ganglia at every level of the spinal cord and the cranial nerve sensory ganglia, notably the trigeminal ganglion and the geniculate ganglion of the facial nerve. Which ganglia are seeded during primary infection determines which dermatomes can later produce shingles, and it is why zoster ophthalmicus and Ramsay Hunt syndrome are possible at all.

Figure: Vesicular rashes in chickenpox (Image source: CDC/PHIL)Three types of lesions are most often seen in varicella-zoster infections; maculopapular lesions (lesions with a raised red bump), vesicular lesions (blister-like or fluid-filled lesions), and scabbed or crusted lesions.

Clinical Manifestations

The incubation period of varicella is 10-21 days.

1. Characteristic vesicular rash (chickenpox vesicle surrounded by an erythematous halo is described as a dewdrop on a rose petal) appears after the incubation period described above.
2. The rash is centripetal: lesions are densest on the trunk, face, and scalp, and sparsest on the distal extremities. Centripetal means "toward the center," so picture the lesions crowding toward the trunk. This is the reverse of the centrifugal pattern of smallpox, where lesions concentrate on the face and limbs.
3. Lesions are bilateral and widely scattered, because the skin is seeded from the bloodstream during secondary viremia rather than from a single nerve.
4. Rashes appear in multiple crops; lesions in various stages of evolution, such as maculopapular, vesicles, and scabs can be found in one area at the same time.
5. Fever appears with each crop of rashes.

Figure: Distribution of chickenpox rashes

Chickenpox is a disease of childhood. If occurs in adults, it is more severe with bullous and hemorrhagic rashes.

If a pregnant mother develops primary VZV infection, the fetus may be affected.

Congenital varicella syndrome follows maternal infection in the first half of pregnancy, with the highest risk between 13 and 20 weeks of gestation. The absolute risk is low, roughly 1 to 2 percent of maternal infections in this window, but the consequences are severe: limb hypoplasia, cicatricial cutaneous scarring in a dermatomal distribution, eye abnormalities (microphthalmia, chorioretinitis, cataracts), and neurological damage (cortical atrophy, seizures, intellectual disability). The dermatomal pattern of the scarring is the diagnostic clue, and it reflects in utero reactivation of the virus along a sensory nerve rather than the primary infection itself.

Maternal rash appearing from 5 days before to 2 days after delivery causes severe neonatal varicella, with mortality reported up to 30 percent in the pre-antiviral era. The timing logic is worth understanding rather than memorizing: transplacental IgG transfer takes about 5 days to reach protective levels in the fetus, so an infant delivered inside that window receives the virus but not the antibody. If maternal rash appears more than 5 days before delivery, protective IgG has crossed and the neonate is usually mildly affected. This window is the indication for VZIG in the newborn.

Complications

Complications are more common in adults and in immunocompromised individuals. Secondary bacterial infection of the skin is the most common complication. Other complications include pneumonia, CNS involvement (cerebellar ataxia, encephalitis, and aseptic meningitis), myocarditis, nephritis, corneal lesions, and arthritis.

Reye's syndrome is a rare but life-threatening complication of aspirin use in children during viral illness, including chickenpox and influenza. It presents as acute non-inflammatory encephalopathy (vomiting progressing to confusion, seizures, and coma) together with fatty degeneration of the liver. The laboratory picture is distinctive and frequently examined: markedly raised transaminases and hyperammonemia with normal or near-normal bilirubin, so the child is not jaundiced despite severe liver involvement. That combination, encephalopathy plus deranged liver enzymes without jaundice in a child recovering from a viral illness, is the exam signature.

Shingles

Zoster or shingles is the recurrent form of varicella-zoster virus infection, which usually occurs later in life when the virus gets reactivated under stress or with immune suppression.

Figure: Shingles rash (Image source: CDC/PHIL)

• Chicken pox-like lesions occur in restricted areas (dermatome) that are innervated by a single ganglion;
• The vesicles appear in a dermatomal distribution, almost always unilaterally
• Skin lesions: Usually in the thorax.
• Shingles of an intercostal nerve produces vesicular eruptions and burning pain in the affected dermatome
• Postherpetic neuralgia (PHN): Persistent burning, aching, or shooting pain in the affected dermatome lasting weeks to months after the rash has resolved. PHN is caused by virus-induced damage to sensory neurons and ganglion cells during reactivation, leading to persistent sensitization of peripheral and central pain pathways. It occurs in approximately 10–18% of shingles patients and is significantly more common in those aged over 60. Early antiviral treatment (within 72 hours of rash onset) reduces but does not eliminate the risk of PHN.
• Maculopapular with an erythematous base, and usually heal in about two weeks.
• Zoster ophthalmicus: Reactivation involving the ophthalmic branch (V1) of the trigeminal nerve can affect the eye, causing keratitis, uveitis, and potentially vision loss. Vesicles on the tip of the nose (Hutchinson's sign) indicate involvement of the nasociliary branch of V1 and signal risk of ocular complications; ophthalmology referral and urgent antiviral therapy are indicated.
• Ramsay Hunt syndrome (herpes zoster oticus): Reactivation at the geniculate ganglion, the sensory ganglion of the facial nerve, causes a triad of severe ear pain, vesicles in the external auditory meatus or on the pinna, and peripheral facial nerve palsy. The apparent puzzle, a motor palsy arising from a sensory ganglion, is resolved by anatomy: the geniculate ganglion sits within the narrow facial canal alongside the motor fibers of CN VII, so inflammation and swelling there compress the motor fibers running past it. Hearing loss and vertigo may occur because CN VIII lies immediately adjacent, but the primary lesion is at the CN VII ganglion. Ramsay Hunt carries a worse prognosis for facial nerve recovery than Bell's palsy, which is why distinguishing the two matters.
• In immunocompromised patients, life-threatening disseminated disease including varicella pneumonia may occur

Chickenpox vs Smallpox

Smallpox was declared eradicated in 1980, but the comparison remains a standard examination question because the two rashes were confused historically and the discriminating features are pure clinical reasoning.

The two most reliable discriminators are lesion synchrony and rash distribution. If every lesion is at the same stage and the rash is heaviest on the face and limbs including palms and soles, that is not chickenpox.

The same reasoning now applies to mpox, which also produces synchronous lesions with palm and sole involvement and, unlike chickenpox, characteristically causes prominent lymphadenopathy.

Diagnosis

The characteristic appearance of lesions both in primary varicella and zoster allows for a presumptive clinical diagnosis. Definitive diagnosis in the laboratory can be achieved by using samples from lesions or blood and testing by the following methods;

Virus culture: Virus can be isolated from the lesions using cell lines. VZV produces HSV-like cytopathic effects such as diffuse rounding and ballooning of infected cells. Virus-specific antigens can be detected in the culture fluids.

Figure: Tzanck test: Note the presence of a multinucleated giant cell (Tzanck cell) in the center. (Image source: CDC PHIL)

Cytopathology: Giemsa staining of scrapings from the ulcer base (Tzanck smear) reveals cytopathological changes similar to HSV infections, such as the formation of multinucleated giant cells.

Antigen detection

Specific viral antigens can be detected using direct immunofluorescence staining.

Serology

Primary VZV infection elicits immunoglobulin G (IgG), IgM, and IgA antibodies. A rising antibody titer can be detected using various serological methods. It is useful to diagnose varicella but less useful in the case of zoster.

Molecular Methods

Polymerase chain reactions (PCR) can be used to detect VZV-specific genes. The presence of the virus DNA can be demonstrated in tissues, vesicular fluid, maculopapular lesions, or crusts from lesions.

Treatment

Chickenpox (Varicella)

In healthy children, chickenpox is generally self-limiting and treatment is supportive; antipyretics, antipruritic agents (e.g. calamine lotion), and good skin hygiene to prevent secondary bacterial infection. Aspirin must never be given to children with chickenpox or any other viral illness, due to the risk of Reye's syndrome.

Antiviral treatment with acyclovir (a nucleoside analogue that is phosphorylated by viral thymidine kinase and then inhibits viral DNA polymerase) is indicated in:

• Adolescents and adults with chickenpox (at higher risk of severe disease and pneumonia)
• Immunocompromised patients of any age
• Neonates with perinatal VZV exposure
• Pregnant women (particularly in the second and third trimesters)
• Patients with severe or complicated disease

Shingles (Herpes Zoster)

Antiviral therapy with valacyclovir or famciclovir (preferred over oral acyclovir for shingles due to better bioavailability and simpler dosing) should be started within 72 hours of rash onset to reduce viral shedding, shorten the duration of illness, and most importantly, reduce the incidence and severity of postherpetic neuralgia. Antivirals started after 72 hours have limited benefit unless new lesions are still forming. Pain management is a central part of shingles care, particularly in older adults where postherpetic neuralgia can persist for months.

Contagiousness of shingles compared with chickenpox. Chickenpox spreads through respiratory aerosols and is highly contagious, with secondary attack rates above 85 percent in susceptible household contacts. Shingles spreads only by direct contact with vesicular fluid, because the virus is not present in respiratory secretions during reactivation. This is why covering the shingles rash substantially reduces transmission risk, and why a patient with localized shingles does not require airborne isolation whereas a patient with chickenpox does. Disseminated zoster in an immunocompromised patient is the exception and must be managed with airborne plus contact precautions.

Prevention and Vaccination

Varicella vaccine (for children) A live attenuated vaccine based on the Oka strain of VZV. Two doses are recommended in most national immunization programs: the first at 12–15 months and the second at 4–6 years. Vaccination has dramatically reduced childhood chickenpox hospitalizations and deaths in countries where it is widely used.

Zoster vaccine (for older adults) The recombinant subunit zoster vaccine (Shingrix) is recommended for all adults aged 50 and older, and also for adults aged 19 and older who are immunodeficient or immunosuppressed, in whom shingles risk is elevated regardless of age. Unlike older live attenuated zoster vaccines, Shingrix contains VZV glycoprotein E (the major target antigen) plus an adjuvant system, and is more than 90% effective at preventing shingles and postherpetic neuralgia in older adults. The mechanism is straightforward: it boosts waning VZV-specific T-cell immunity before it falls low enough for reactivation to occur.

Post-exposure prophylaxis Varicella-zoster immunoglobulin (VZIG) is available for post-exposure prophylaxis in high-risk non-immune individuals including immunocompromised patients, pregnant women, and neonates born to mothers with active varicella. It is given within 96 hours of exposure.

Why the two vaccines are built differently. The varicella vaccine contains live attenuated virus, which means it establishes latency in sensory ganglia just as wild-type VZV does. Vaccine-strain zoster is therefore possible, though it is rare and milder than wild-type shingles. Shingrix contains no live virus at all, only glycoprotein E plus the AS01B adjuvant, so it cannot establish latency and cannot cause zoster. This difference also explains their contraindications: the live varicella vaccine is contraindicated in pregnancy and in significant immunosuppression, while Shingrix is safe in immunocompromised adults and is specifically recommended for them.

How to Remember

Primary vs. reactivation disease in one image: the same virus, two completely different patterns. Chickenpox is centripetal (trunk more than extremities), bilateral, multiple crops in various stages simultaneously, and appears all over the body because viremia seeds the skin widely. Shingles is unilateral, dermatomal, and follows one nerve's territory exactly, because the virus isn't spreading through the blood this time, it's traveling back down one specific axon from one specific ganglion. The distribution difference directly maps onto the biological difference between hematogenous spread (primary) and axonal transport (reactivation).

The "dewdrop on a rose petal" is the single most memorable chickenpox finding. A small, clear, fluid-filled vesicle on an erythematous base. If you can picture a dewdrop on a red petal, you can picture a chickenpox lesion. This description is so specific that recognizing it immediately suggests VZV in a clinical or exam context.

"Crops" means different stages simultaneously: the most characteristic chickenpox finding. Unlike many viral rashes that progress uniformly, chickenpox appears in multiple crops over several days, so at any one time you can see maculopapules, vesicles, and crusted lesions all on the same skin area. This simultaneous multi-stage presentation is not seen in smallpox (all lesions the same stage simultaneously); the distinction was historically important for differentiating the two diseases.

Latency is held in check by T-cells, not antibodies. This is worth anchoring explicitly because it's the opposite of what drives vaccine-preventable antibody-mediated diseases. VZV antibodies don't prevent reactivation; it's the cell-mediated immune response that keeps the latent virus suppressed. This is why immunocompromised states that primarily affect T-cell function (HIV, post-transplant immunosuppression, corticosteroid therapy) dramatically increase shingles risk, even in individuals with plenty of circulating anti-VZV antibodies.

Hutchinson's sign: vesicles on the nose tip = eye in danger. When shingles involves the ophthalmic branch of the trigeminal nerve (zoster ophthalmicus), involvement of the nasociliary branch (which supplies both the tip of the nose and the eye) signals risk of corneal and ocular involvement. Vesicles on the tip of the nose are Hutchinson's sign, an urgent flag to involve ophthalmology and start systemic antivirals. The mnemonic is simple: "nose tip, eye tip"; if the tip of the nose is involved, the eye may follow.

Key Exam Facts Table

Where Students Get Confused

"Aspirin is fine to give to a feverish child with chickenpox." It is not, this is one of the most clinically dangerous misconceptions a student can carry into practice. Aspirin given to children with viral illnesses (particularly VZV and influenza) is associated with Reye's syndrome: a rare but life-threatening condition causing acute encephalopathy with fatty liver degeneration, historically fatal in roughly 20 to 40 percent of cases. The mechanism involves mitochondrial dysfunction triggered by the combination of salicylates and viral illness. Paracetamol (acetaminophen) or ibuprofen are used instead. This contraindication extends to all children under 16 with any viral illness, not just chickenpox.

"VZV antibodies prevent shingles." They don't. Antibody titers against VZV remain high for life in previously infected individuals, but shingles still develops because its prevention depends on cell-mediated immunity, specifically VZV-specific T-cell surveillance in dorsal root ganglia. The waning of T-cell immunity with age is why shingles incidence increases sharply after age 50, despite stable antibody levels. The zoster vaccine (Shingrix) works by boosting T-cell immunity, not antibody titers.

"Shingles can spread to contacts and cause shingles." Not directly. A person with active shingles can transmit VZV to a non-immune contact via direct contact with vesicular fluid, but the contact would develop chickenpox (primary VZV infection), not shingles. Shingles is always the result of reactivation of a person's own latent virus, not a new infection from someone else.

"The Tzanck smear differentiates VZV from HSV." It does not. Both VZV and HSV produce multinucleated giant cells (Tzanck cells) on Giemsa-stained smears. The Tzanck smear confirms a herpesvirus infection but cannot distinguish which one. PCR or direct immunofluorescence with virus-specific antibodies is required to differentiate VZV from HSV definitively.

"Shingles only occurs in very elderly patients." In immunocompetent individuals, shingles incidence does increase sharply with age (reflecting waning T-cell immunity). However, shingles can occur at any age in immunocompromised patients; people with HIV, patients on prolonged corticosteroid therapy, chemotherapy recipients, and organ transplant recipients are all at significantly elevated risk regardless of age.

References and further readings

1. Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G., Oxman, M. N., Rall, G., & Silverstein, S. J. (2015). Varicella zoster virus infection. Nature Reviews Disease Primers, 1, 15016. https://doi.org/10.1038/nrdp.2015.16
2. Laing, K. J., Ouwendijk, W. J. D., Koelle, D. M., & Verjans, G. M. G. M. (2018). Immunobiology of varicella-zoster virus infection. Journal of Infectious Diseases, 218(Suppl 2), S68–S74. https://doi.org/10.1093/infdis/jiy403
3. De Paschale, M., & Clerici, P. (2016). Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World Journal of Virology, 5(3), 97–124. https://doi.org/10.5501/wjv.v5.i3.97
4. Nair, P. A., & Patel, B. C. (2023). Herpes zoster. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441824/